Halozyme Therapeutics shares owned by Legal & General Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Legal & General Group
from 13F filings
Historical chart of Legal & General Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Legal & General Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $8.9M | 218k | 40.68 |
2023-12-31 | $8.4M | 227k | 36.96 |
2023-09-30 | $9.0M | 236k | 38.20 |
2023-06-30 | $8.8M | 243k | 36.07 |
2023-03-31 | $11M | 285k | 38.19 |
2022-12-31 | $14M | 238k | 56.90 |
2022-09-30 | $9.4M | 238k | 39.54 |
2022-06-30 | $12M | 272k | 44.00 |
2022-03-31 | $12M | 292k | 39.88 |
2021-12-31 | $12M | 295k | 40.21 |
2021-09-30 | $12M | 295k | 40.68 |
2021-06-30 | $12M | 258k | 45.42 |
2021-03-31 | $9.2M | 221k | 41.69 |
2020-12-31 | $9.5M | 222k | 42.70 |
2020-09-30 | $2.9M | 110k | 26.29 |
2020-06-30 | $3.3M | 122k | 26.81 |
2020-03-31 | $1.8M | 102k | 17.72 |
2019-12-31 | $2.0M | 114k | 17.75 |
2019-09-30 | $1.4M | 92k | 15.44 |
2019-06-30 | $1.2M | 69k | 17.18 |
2019-03-31 | $884k | 55k | 16.09 |
2018-12-31 | $1.0M | 69k | 14.66 |
2018-09-30 | $1000k | 55k | 18.18 |
2018-06-30 | $724k | 43k | 16.87 |
2018-03-31 | $880k | 45k | 19.60 |
2017-12-31 | $1.2M | 59k | 20.25 |
2017-09-30 | $1.0M | 60k | 17.39 |
2017-06-30 | $567k | 44k | 12.85 |
2017-03-31 | $500k | 39k | 12.97 |
2016-12-31 | $385k | 39k | 9.87 |
2016-09-30 | $318k | 27k | 11.90 |
2016-06-30 | $232k | 27k | 8.49 |
2016-03-31 | $261k | 27k | 9.55 |
2015-12-31 | $379k | 22k | 17.27 |
2015-09-30 | $276k | 21k | 13.34 |
2015-06-30 | $456k | 21k | 22.05 |
2015-03-31 | $293k | 21k | 14.17 |
2014-12-31 | $153k | 16k | 9.65 |
2014-09-30 | $147k | 16k | 9.27 |